Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
Yousef Nassar, Seth Richter
J Bone Metab. 2018;25(3):141-151.   Published online 2018 Aug 31     DOI: https://doi.org/10.11005/jbm.2018.25.3.141
Citations to this article as recorded by Crossref logo
The therapeutic importance of acid-base balance
Bianca N. Quade, Mark D. Parker, Rossana Occhipinti
Biochemical Pharmacology.2021; 183: 114278.     CrossRef
Actualización en la prescripción de inhibidores de la bomba de protones. Qué hacer y qué no hacer
G.M. Saiz Ladera, M.E. Pejenaute Labari, J.N. García Pascual
Medicina de Familia. SEMERGEN.2021; 47(4): 267.     CrossRef
Different elemental infant formulas show equivalent phosphorus and calcium bioavailability in healthy volunteers
Clemens Bergwitz, Simone R.B.M. Eussen, Pilou L.H.R. Janssens, Monique Visser, Thomas O. Carpenter, Ardy van Helvoort
Nutrition Research.2021; 85: 71.     CrossRef
Herbal medicines in functional dyspepsia—Untapped opportunities not without risks
Kok‐Ann Gwee, Gerald Holtmann, Jan Tack, Hidekazu Suzuki, Jinsong Liu, Yinglian Xiao, Min‐Hu Chen, Xiaohua Hou, Deng‐Chyang Wu, Clarissa Toh, Fang Lu, Xu‐Dong Tang
Neurogastroenterology & Motility.2021;[Epub]     CrossRef
Proton Pump Inhibitors and Fractures in Adults: A Critical Appraisal and Review of the Literature
Silvia Irina Briganti, Anda Mihaela Naciu, Gaia Tabacco, Roberto Cesareo, Nicola Napoli, Pierpaolo Trimboli, Marco Castellana, Silvia Manfrini, Andrea Palermo, Arturo Bevilacqua
International Journal of Endocrinology.2021; 2021: 1.     CrossRef
Low-dose PPI to prevent bleeding after ESD: A multicenter randomized controlled study
Li Yang, Jian Qi, Weiqing Chen, Qinghong Guo, Rui Xie, Zhifeng Zhao, Shanyu Qin, Aiming Liu, Mingming Den, Chaoqiang Fan, Jianyin Bai, Hui Lin, Hong Guo, Shiming Yang
Biomedicine & Pharmacotherapy.2021; 136: 111251.     CrossRef
Comment on: Metabolic bone changes after bariatric surgery: 2020 update, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee position statement
Michel Gagner
Surgery for Obesity and Related Diseases.2021; 17(6): 1229.     CrossRef
Use of proton pump inhibitors is associated with lower hemoglobin levels in people with cystic fibrosis
Alex H. Gifford, Julie L. Sanville, Meghana Sathe, Sonya L. Heltshe, Christopher H. Goss
Pediatric Pulmonology.2021; 56(7): 2048.     CrossRef
Phosphorus bioaccessibility measured in four amino acid–based  formulas using in-vitro batch digestion translates well into phosphorus bioavailability in mice
Sampada Chande, Francina Dijk, Jonathan Fetene, Steven Yannicelli, Thomas O. Carpenter, Ardy van Helvoort, Clemens Bergwitz
Nutrition.2021; 89: 111291.     CrossRef
Umbrella review of 42 systematic reviews with meta‐analyses: the safety of proton pump inhibitors
Elizabeth M. Salvo, Nicole C. Ferko, Sarah B. Cash, Ailish Gonzalez, Peter J. Kahrilas
Alimentary Pharmacology & Therapeutics.2021; 54(2): 129.     CrossRef
Effect of Omeprazole on Osteoblasts and Osteoclasts in vivo and in the in vitro Model Using Fish Scales
Mohamed I. Zanaty, Adel Abdel-Moneim, Yoichiro Kitani, Toshio Sekiguchi, Nobuo Suzuki
Biochemistry (Moscow).2021; 86(10): 1192.     CrossRef
Влияние омепразола на остеобласты и остеокласты in vivo и в модели in vitro с использованием чешуи рыбы
M.I. Zanaty, A. Abdel-Moneim, Y. Kitani, T. Sekiguchi, N. Suzuki
Биохимия.2021; 86(10): 1423.     CrossRef
Long-term use of proton pump inhibitors adversely affects minerals and vitamin metabolism, bone turnover, bone mass, and bone strength
Md. Saddam Hussain, Tanoy Mazumder
Journal of Basic and Clinical Physiology and Pharmacology.2021;[Epub]     CrossRef
Association of proton‐pump inhibitor use with adverse health outcomes: A systematic umbrella review of meta‐analyses of cohort studies and randomised controlled trials
Sajesh K. Veettil, Saranrat Sadoyu, Elizabeth M Bald, Viji P. Chandran, Scott Anh Tuan Khuu, Panitan Pitak, Yeong Yeh Lee, Athira Balakrishnan Nair, Paul T. Antony, Alexander C. Ford, Nathorn Chaiyakunapruk
British Journal of Clinical Pharmacology.2021;[Epub]     CrossRef
Proton-Pump Inhibitors: Do Children Break a Leg by Using Them?
Marta Tavares, Jorge Amil-Dias
Journal of Pediatric Gastroenterology & Nutrition.2021; 73(6): 665.     CrossRef
Hospitalized fracture rates amongst patients with chronic kidney disease in Australia using data linkage
Raymond Lin, Nigel D. Toussaint, Martin Gallagher, Alan Cass, Sradha Kotwal
Nephrology.2020; 25(6): 475.     CrossRef
Targeted Therapies for Eosinophilic Gastrointestinal Disorders
Alfredo J. Lucendo, Piedad López-Sánchez
BioDrugs.2020; 34(4): 477.     CrossRef

Effects of Calcium and Annatto Tocotrienol Supplementation on Bone Loss Induced by Pantoprazole in Male Rats

Kok-Yong Chin, Benjamin Ka Seng Thong, Rhivaldy Faahim Kamalulloh, Nur Vaizura Mohamad, Sok Kuan Wong, Azlan Mohd Arlamsyah, Rahma Triliana, Ima Nirwana Soelaiman
Drug Design, Development and Therapy.2020; Volume 14: 2561.     CrossRef
Potential proton pump inhibitor–related adverse effects
Issac E. Perry, Irene Sonu, Carmelo Scarpignato, Junichi Akiyama, Michio Hongo, Kenneth J. Vega
Annals of the New York Academy of Sciences.2020; 1481(1): 43.     CrossRef
The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors
Nathan Fleishman, Troy Richardson, Thomas Attard
Journal of Pediatric Gastroenterology & Nutrition.2020; 70(6): 815.     CrossRef
Pharmacological treatments for eosinophilic esophagitis: current options and emerging therapies
Alfredo J Lucendo
Expert Review of Clinical Immunology.2020; 16(1): 63.     CrossRef
Proton Pump Inhibitors and Osteoporosis: Is Collagen a Direct Target?
Yohannes T. Ghebre
Frontiers in Endocrinology.2020;[Epub]     CrossRef
Association between proton pump inhibitor use and risk of fracture: A population-based case-control study
Jong Joo Kim, Eun Jin Jang, Jiwon Park, Hyun Soon Sohn, Robert Daniel Blank
PLOS ONE.2020; 15(7): e0235163.     CrossRef
Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies
Hee-Eun Hong, A-Sol Kim, Mi-Rae Kim, Hae-Jin Ko, Min Kyu Jung
Cancers.2020; 12(8): 2220.     CrossRef
Evidence-based application of explicit criteria to assess the appropriateness of geriatric prescriptions at admission and hospital stay
Enrica Di Martino, Alessio Provenzani, Piera Polidori, Vincenzo De Luca
PLOS ONE.2020; 15(8): e0238064.     CrossRef
Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review)
Leon Fisher, Alexander Fisher, Paul N Smith
Journal of Clinical Medicine.2020; 9(10): 3253.     CrossRef
Effect of proton pump inhibitors on bone mineral density: A systematic review and meta-analysis of observational studies
Sara Aleraij, Sultan Alhowti, Mazen Ferwana, Imad Abdulmajeed, Ibrahim Mohsen Mutawwam
Bone Reports.2020; 13: 100732.     CrossRef
Diabetes Mellitus and Osteoporosis Correlation: Challenges and Hopes
Moein Ala, Razieh Mohammad Jafari, Ahmad Reza Dehpour
Current Diabetes Reviews.2020; 16(9): 984.     CrossRef
Proton pump inhibitors therapy and risk of bone diseases: An update meta-analysis
Jian Liu, Xianqing Li, Lei Fan, Jie Yang, Jiecong Wang, Jiaming Sun, Zhenxing Wang
Life Sciences.2019; 218: 213.     CrossRef
Proton Pump Inhibitor Use and Fracture Risk: An Update of Drug Safety Communication Needed?
Toshihiro Sugiyama
American Journal of Gastroenterology.2019; 114(2): 360.     CrossRef
Association of Proton Pump Inhibitor Use and Risk of Fracture Based on the National Health Insurance Sample Cohort Database (2002~2013)
Jong Joo Kim, Eun Jin Jang, Junwoo Cho, Hyun Soon Sohn
Korean Journal of Clinical Pharmacy.2019; 29(3): 147.     CrossRef
Association between Peptic Ulcer Disease and Osteoporosis: The Population-Based Longitudinal Cohort Study in Korea
Phill Hoon Yoon, Sang Joon An, Seok-Hoo Jeong, Yun-Jung Yang, Yeon-pyo Hong
International Journal of Environmental Research and Public Health.2019; 16(15): 2777.     CrossRef